Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$6,237,400
+$342,769 QoQ
Shares Held
24,787
-8.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
#1,180
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUE Private Wealth Advisors holds $27,309,850 across 8 Drug Manufacturers - General names. ABBV ranks #3 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,739 | $8,082,959 | |
| 2 | JNJ |
Johnson & Johnson
|
26,804 | $6,807,411 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
24,787 | $6,237,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,029 | $3,473,226 | |
| 5 | PFE |
Pfizer Inc
|
66,968 | $1,612,589 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,727 | $560,469 | |
| 7 | AMGN |
Amgen Inc
|
808 | $292,592 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,925 | $243,204 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,237,400 | 24,787 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,894,631 | 27,103 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,190,251 | 27,092 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,253,895 | 27,010 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,942,318 | 26,626 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,628,126 | 26,862 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,126,645 | 28,850 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,770,365 | 29,220 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,067,215 | 29,543 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $5,739,427 | 31,518 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $5,800,217 | 37,428 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $5,221,422 | 35,029 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,507,661 | 33,457 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,380,171 | 33,759 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,370,138 | 33,229 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,398,732 | 32,775 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $4,570,141 | 29,839 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,742,365 | 29,254 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,156,979 | 38,087 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,854,195 | 35,730 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $4,093,562 | 36,342 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,784,886 | 34,974 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,596,382 | 33,564 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $2,941,972 | 33,588 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $3,353,239 | 34,154 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $2,556,631 | 33,556 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||